Psychiatry Text Module

CE / CME

Integrating Brain Health Discussions Into Clinical Practice: Psychiatry

Physician Assistants/Physician Associates: 0.75 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.75 Nursing contact hour

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

ABIM MOC: maximum of 0.75 Medical Knowledge MOC point

Released: March 26, 2025

Expiration: March 25, 2026

Activity

Progress
1 2
Course Completed

References

  1. Rost NS, Salinas J, Jordan JT, et al. The brain health imperative in the 21st century-a call to action: The AAN brain health platform and position statement. Neurology. 2023;101:570-579.
  2. Syed SA, Nemeroff CB. Early life stress, mood, and anxiety disorders. Chronic Stress (Thousand Oaks). 2017;1:2470547017694461.
  3. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024;20:3708-3821.
  4. Atri A. The Alzheimer’s disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019;103:263-293.
  5. Zhang J, Zhang Y, Wang J, et al. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9:211.
  6. Liang CS, Li DJ, Yang FC, et al. Mortality rates in Alzheimer’s disease and non-Alzheimer’s dementias: a systematic review and meta-analysis. Lancet Healthy Longev. 2021;2:e479-e488.
  7. Younes L, Albert M, Moghekar AI, et al. Identifying changepoints in biomarkers during the preclinical phase of Alzheimer's disease. Front Aging Neurosci. 2019;11:74. 
  8. Vermunt L, Sikkes SAM, van den Hout A, et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019;15:888-898.
  9. Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14:535-562.
  10. Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement. 2024;20:5143-5169.
  11. Dubois B, Villain N, Schneider L, et al. Alzheimer disease as a clinical-biological construct-an International Working Group recommendation. JAMA Neurol. 2024;81:1304-1311.
  12. Rafii MS, Sperling RA, Donohue MC, et al. The AHEAD 3-45 Study: design of a prevention trial for Alzheimer's disease. Alzheimers Dement. 2023;19:1227-1233.
  13. Yaari R, Holdridge K, Ferguson M, et al. Decentralized approaches in TRAILBLAZER-ALZ 3 (P7-6.006). Neurology. 2023;100(17_suppl_2):3010.
  14. American Psychiatric Association. Desk Reference to the Diagnostic Criteria from DSM-5. Arlington: American Psychiatric Association; 2016.
  15. Schindler SE, Atri A. The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution. Nat Aging. 2023;3:460-462.
  16. Atri A, Dickerson BC, Clevenger C, et al. Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): executive summary of recommendations for primary care. Alzheimers Dement. 2024;Epub ahead of print.
  17. Dickerson BC, Atri A, Clevenger C, et al. The Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders (DETeCD-ADRD): executive summary of recommendations for specialty care. Alzheimers Dement. 2025;21:e14337.
  18. Atri A, Dickerson BC, Clevenger C, et al. The Alzheimer’s Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer’s disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments. Alzheimers Dement. 2025;21:e14335.
  19. Lazar RM, Howard VJ, Kernan WN, et al. A primary care agenda for brain health: a scientific statement from the American Heart Association. Stroke. 2021;52:e295-e308.
  20. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572-628.
  21. Keil SA, Schindler AG, Wang MX, et al. Longitudinal sleep patterns and cognitive impairment in older adults. JAMA Netw Open. 2023;6:e2346006.
  22. Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11:1015-1022.
  23. Agarwal P, Leurgans SE, Agrawal S, et al. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023;100:e2259-e2268.
  24. Kivimäki M, Walker KA, Pentti J, et al. Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies. BMJ. 2021;374:n1804. Published 2021 Aug 18. doi:10.1136/bmj.n1804
  25. Sommerlad A, Kivimäki M, Larson EB, et al. Social participation and risk of developing dementia. Nat Aging. 2023;3(5):532-545. doi:10.1038/s43587-023-00387-0
  26. Shen C, Zhang R, Yu J, et al. Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality. Nat Hum Behav. 2025;[Epub ahead of print].
  27. Baranowski BJ, Marko DM, Fenech RK, et al. Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer’s disease risk. Appl Physiol Nutr Metab. 2020;45:1055-1065.
  28. Liss JL, Seleri Assunção S, Cummings J, et al. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis. J Intern Med. 2021;290:310-334.